EG-62054

N/A

Report date: 2023/04/01 22:49:12

Base Information

Drug NameEG-62054

Drug Alias NameEG-62054

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionVascular endothelial growth factor A inhibitors

TargetsVascular endothelial growth factor A

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEirgenix Inc

China Registration ClassN/A

Active CompaniesEirgenix Inc

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A